VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA). H. Lundbeck A/S...
Hence then, the article about lundbeck s potential treatment for multiple system atrophy granted orphan drug designation in japan was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan )
Also on site :
- The White Sox Have Decisions To Make With Munetaka Murakami
- Sam's Club Delights Shoppers By Bringing Back One of its Top-Selling Snacks: 'I Am Completely Addicted'
- Anthropic says engineering missteps were behind Claude Code’s monthlong decline after weeks of user backlash